Cardiomyocyte Adhesion and Hyper-Adhesion Differentially Require ERK1/2 and Plakoglobin

Total Page:16

File Type:pdf, Size:1020Kb

Cardiomyocyte Adhesion and Hyper-Adhesion Differentially Require ERK1/2 and Plakoglobin Cardiomyocyte adhesion and hyper-adhesion differentially require ERK1/2 and plakoglobin Maria Shoykhet, … , Sunil Yeruva, Jens Waschke JCI Insight. 2020. https://doi.org/10.1172/jci.insight.140066. Research In-Press Preview Cardiology Graphical abstract Find the latest version: https://jci.me/140066/pdf 1 Research Article 2 Cardiomyocyte adhesion and hyper-adhesion differentially require ERK1/2 and 3 plakoglobin. 4 Maria Shoykhet1, Sebastian Trenz1, Ellen Kempf1, Tatjana Williams2, Brenda Gerull2, 5 Camilla Schinner1+, Sunil Yeruva§1 and Jens Waschke§1 6 1Faculty of Medicine, Ludwig-Maximilians-University (LMU) Munich, Munich, Germany 7 2Comprehensive Heart Failure Center and Department of Internal Medicine I, University 8 Hospital Würzburg, Würzburg, Germany 9 + Current address: Department of Biomedicine, University of Basel, Basel, Switzerland 10 §Corresponding authors: 11 Sunil Yeruva and Jens Waschke, Institute of Anatomy and Cell Biology, Department I, 12 Ludwig-Maximilians-University, Pettenkoferstraße 11, 80336 Munich, Germany; Phone: 13 +49-89-2180-72610; Fax: +49-89-2180-72602; [email protected], 14 [email protected] 15 16 Conflict of Interest 17 The authors declare that no conflict of interest exists. 18 1 19 Abstract: 20 Arrhythmogenic cardiomyopathy (AC) is a heart disease often caused by mutations in genes 21 coding for desmosomal proteins including desmoglein-2 (DSG2), plakoglobin (PG), and 22 desmoplakin (DP). Therapy is symptomatic to limit arrhythmia since the mechanisms by 23 which desmosomal components control cardiomyocyte function are largely unknown. A new 24 paradigm would be to stabilize desmosomal cardiomyocyte adhesion and hyper-adhesion, 25 which renders desmosomal adhesion independent from Ca2+. Here, we further characterized 26 the mechanisms behind enhanced cardiomyocyte adhesion and hyper-adhesion. Dissociation 27 assays performed in HL-1 cells and murine ventricular cardiac slice cultures allowed us to 28 define a set of signaling pathways regulating cardiomyocyte adhesion under basal and hyper- 29 adhesive conditions. Adrenergic signaling, activation of PKC and inhibition of p38MAPK 30 enhanced cardiomyocyte adhesion, referred to as positive adhesiotropy, and induced hyper- 31 adhesion. Activation of ERK1/2 paralleled positive adhesiotropy, whereas adrenergic 32 signaling induced Pg phosphorylation at S665 under both basal and hyper-adhesive 33 conditions. Adrenergic signaling and p38MAPK inhibition recruited DSG2 to cell junctions. 34 In PG-deficient mice with an AC phenotype, only PKC activation and p38MAPK inhibition 35 enhanced cardiomyocyte adhesion. Our results demonstrate that cardiomyocyte adhesion can 36 be stabilized by different signaling mechanisms, which are in part off-set in PG-deficient AC. 37 2 38 1. Introduction 39 In the heart, cardiomyocytes are coupled via intercalated disks (ICD) consisting of 40 desmosomes, adherens junctions (AJ) and gap junctions (GJ), which together allow 41 mechanical stability and electrical conduction of the heart muscle (1). Cardiomyocytes 42 express desmosomal cadherins desmoglein-2 (DSG2) and desmocollin-2 (DSC2) and the AJ 43 protein N-Cadherin (N-CAD) (2). The cytosolic part of these adhesion molecules connects to 44 the cytoskeletal network via the plaque proteins plakoglobin (PG), plakophilin (PKP), and 45 desmoplakin (DP) in desmosomes or to β-catenin and other plaque proteins in AJs, 46 respectively. Adjacent cardiomyocytes attach via DSG2, DSC2, and N-CAD, which bind to 47 their respective partners extracellularly in a Ca2+-dependent manner (3). Cardiomyocyte 48 function markedly relies on the proper function of desmosomal and AJ proteins since 49 mutations in these genes lead to an arrhythmic heart disorder called arrhythmogenic 50 cardiomyopathy (AC) (4, 5). The progressive loss of cardiomyocytes with cardiac fibrosis, 51 ventricular dilatation, and arrhythmia accompanied by a high risk for sudden cardiac death, 52 especially in young athletes, are the characteristics of AC. The mechanisms by which 53 desmosomal components serve heart function and how cardiomyocyte adhesion is regulated 54 in pathological conditions are poorly understood. Thus, therapy of AC is symptomatic and 55 focused on limiting arrhythmia in patients. In this context, desmosomal components are 56 thought to regulate conduction of excitation via GJ and the cardiac sodium channel complex 57 allowing ephaptic conduction (6, 7). Therefore, characterization of mechanisms regulating 58 desmosomal adhesion can help to establish new experimental approaches to treat desmosomal 59 diseases, as has been shown for pemphigus (1), a disease caused by autoantibodies primarily 60 against DSG1 and DSG3, leading to severe blistering of the skin and mucosa (8, 9). For 61 pemphigus, the mechanisms controlling keratinocyte adhesion have been studied extensively 62 and were found to focus on p38MAPK, PKC, ERK1/2, and cAMP-signaling (10-12), whereas 3 63 others, such as SRC appear not to be central for the disease (13). The context of pemphigus is 64 relevant for AC for two aspects: Firstly, AC is known to occur in syndromes, also affecting 65 the skin and its appendices when specific mutations in genes coding for PG or DP are 66 causative (14-16). Secondly, most recently, it has been proposed that different mutations in 67 desmosomal genes causing AC can induce the formation of autoantibodies against 68 cardiomyocyte antigens, including DSG2, which are pathogenic and thus may aggravate the 69 disease (17, 18). This would imply that the mechanisms causing AC and pemphigus may be at 70 least in part comparable. Therefore, in order to establish new therapeutic approaches for AC, 71 it is pivotal to characterize the molecular mechanisms regulating cardiomyocyte adhesion in 72 detail. Such therapeutic approaches might focus on enhancing cardiomyocyte adhesion and 73 thus prevent fibro-fatty replacement with the subsequent occurrence of arrhythmias. 74 Although desmosomal cadherins depend on the presence of extracellular Ca2+, it was shown 75 that in keratinocytes, desmosomes acquire a Ca2+-independent state, referred to as hyper- 76 adhesion, and which was proposed to be the primary adhesive state of desmosomes in intact 77 epidermis (19-21). This phenomenon was not explored further in other tissues. Indeed, in a 78 previous study, we found that in cardiomyocytes, adrenergic signaling leads to the 79 enhancement of basal cellular adhesion, which we referred to as positive adhesiotropy, and 80 also causes hyper-adhesion (22). Since cardiac muscle contractions depend on Ca2+, which is 81 tightly regulated intra- and extracellularly, it is possible that a hyper-adhesive state similar to 82 keratinocytes exists in the physiologic state of desmosomes in cardiomyocytes. Thus, the 83 signaling mechanisms regulating hyper-adhesion in cardiomyocytes need to be investigated. 84 In multiple heart diseases including myocardial dysfunction, diabetic cardiomyopathy, 85 hypertrophy, fibrosis, and heart failure, MAPK signaling pathways, such as ERK1/2, JNK, 86 and p38MAPK, are demonstrated to be involved in disease pathogenesis (23-25). Besides, 87 PKC has been shown to be important in the regulation of GJs in cardiomyocytes (26, 27). 88 Moreover, in previous studies, we found that activation of PKC (28) and adrenergic signaling 4 89 enhance cardiomyocyte adhesion, the latter of which is mediated through PKA pathway 90 induced PG phosphorylation at S665 (22). 91 In this study, we investigated the signaling pathways that enhance cardiomyocyte adhesion 92 and may induce hyper-adhesion of desmosomal contacts. Our results show that enhancement 93 of cAMP levels by adrenergic signaling, activation of PKC as well as inhibition of p38MAPK 94 enhance basal cardiomyocyte adhesion and cause hyper-adhesion. ERK1/2 was found to be 95 critical to enhance basal cardiomyocyte adhesion, i.e., for positive adhesiotropy, which was 96 dependent on PG, DP, and DSG2 in cultured cardiomyocytes. In ventricular cardiac slices 97 obtained from PG-deficient mice with an AC phenotype, adrenergic signaling failed to 98 enhance cardiomyocyte adhesion, whereas PKC activation and p38MAPK inhibition were 99 still effective. On the other hand, ERK1/2 activation did not play a role in hyper-adhesion 100 caused by the above signaling pathways, indicating that the mechanisms to enhance 101 cardiomyocyte adhesion at least in part are different between basal and hyper-adhesive 102 conditions. 5 103 2. Results 104 2.1.Adrenergic signaling, PKC and p38MAPK regulate cardiomyocyte adhesion in 105 HL-1 cells and murine ventricular cardiac slices 106 In keratinocytes, a Ca2+-independent desmosomal adhesion, which is called hyper-adhesion, 107 has been identified (19-21). In a previous study, we observed a similar phenomenon in 108 cultured HL-1 cardiomyocytes (22). In this study, we first determined the Ca2+-dependency of 109 cardiomyocyte adhesion using dissociation assays. In dissociation assays cells are treated with 110 dispase and collagenase to detach cell monolayers from the well bottoms and a standardized 111 mechanical stress is applied to the monolayers. The resulting fragmentation serves as an 112 indirect measurement of cell-cell cohesion; a higher amount of fragmentation indicates a 113 weaker cell-cell cohesion and vice versa. However, it has to be noted that the assay measures 114 overall cell cohesion and cannot discriminate between adhesion provided by desmosomal 115 cadherins and classical cadherins
Recommended publications
  • Human Periprostatic Adipose Tissue: Secretome from Patients With
    CANCER GENOMICS & PROTEOMICS 16 : 29-58 (2019) doi:10.21873/cgp.20110 Human Periprostatic Adipose Tissue: Secretome from Patients With Prostate Cancer or Benign Prostate Hyperplasia PAULA ALEJANDRA SACCA 1, OSVALDO NÉSTOR MAZZA 2, CARLOS SCORTICATI 2, GONZALO VITAGLIANO 3, GABRIEL CASAS 4 and JUAN CARLOS CALVO 1,5 1Institute of Biology and Experimental Medicine (IBYME), CONICET, Buenos Aires, Argentina; 2Department of Urology, School of Medicine, University of Buenos Aires, Clínical Hospital “José de San Martín”, Buenos Aires, Argentina; 3Department of Urology, Deutsches Hospital, Buenos Aires, Argentina; 4Department of Pathology, Deutsches Hospital, Buenos Aires, Argentina; 5Department of Biological Chemistry, School of Exact and Natural Sciences, University of Buenos Aires, Buenos Aires, Argentina Abstract. Background/Aim: Periprostatic adipose tissue Prostate cancer (PCa) is the second most common cancer in (PPAT) directs tumour behaviour. Microenvironment secretome men worldwide. While most men have indolent disease, provides information related to its biology. This study was which can be treated properly, the problem consists in performed to identify secreted proteins by PPAT, from both reliably distinguishing between indolent and aggressive prostate cancer and benign prostate hyperplasia (BPH) disease. Evidence shows that the microenvironment affects patients. Patients and Methods: Liquid chromatography-mass tumour behavior. spectrometry-based proteomic analysis was performed in Adipose tissue microenvironment is now known to direct PPAT-conditioned media (CM) from patients with prostate tumour growth, invasion and metastases (1, 2). Adipose cancer (CMs-T) (stage T3: CM-T3, stage T2: CM-T2) or tissue is adjacent to the prostate gland and the site of benign disease (CM-BPH). Results: The highest number and invasion of PCa.
    [Show full text]
  • Plakoglobin Is Required for Effective Intermediate Filament Anchorage to Desmosomes Devrim Acehan1, Christopher Petzold1, Iwona Gumper2, David D
    ORIGINAL ARTICLE Plakoglobin Is Required for Effective Intermediate Filament Anchorage to Desmosomes Devrim Acehan1, Christopher Petzold1, Iwona Gumper2, David D. Sabatini2, Eliane J. Mu¨ller3, Pamela Cowin2,4 and David L. Stokes1,2,5 Desmosomes are adhesive junctions that provide mechanical coupling between cells. Plakoglobin (PG) is a major component of the intracellular plaque that serves to connect transmembrane elements to the cytoskeleton. We have used electron tomography and immunolabeling to investigate the consequences of PG knockout on the molecular architecture of the intracellular plaque in cultured keratinocytes. Although knockout keratinocytes form substantial numbers of desmosome-like junctions and have a relatively normal intercellular distribution of desmosomal cadherins, their cytoplasmic plaques are sparse and anchoring of intermediate filaments is defective. In the knockout, b-catenin appears to substitute for PG in the clustering of cadherins, but is unable to recruit normal levels of plakophilin-1 and desmoplakin to the plaque. By comparing tomograms of wild type and knockout desmosomes, we have assigned particular densities to desmoplakin and described their interaction with intermediate filaments. Desmoplakin molecules are more extended in wild type than knockout desmosomes, as if intermediate filament connections produced tension within the plaque. On the basis of our observations, we propose a particular assembly sequence, beginning with cadherin clustering within the plasma membrane, followed by recruitment of plakophilin and desmoplakin to the plaque, and ending with anchoring of intermediate filaments, which represents the key to adhesive strength. Journal of Investigative Dermatology (2008) 128, 2665–2675; doi:10.1038/jid.2008.141; published online 22 May 2008 INTRODUCTION dense plaque that is further from the membrane and that Desmosomes are large macromolecular complexes that mediates the binding of intermediate filaments.
    [Show full text]
  • Genome Editing for the Understanding and Treatment of Inherited Cardiomyopathies
    International Journal of Molecular Sciences Review Genome Editing for the Understanding and Treatment of Inherited Cardiomyopathies 1, 1, 1,2, Quynh Nguyen y , Kenji Rowel Q. Lim y and Toshifumi Yokota * 1 Department of Medical Genetics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB T6G2H7, Canada; [email protected] (Q.N.); [email protected] (K.R.Q.L.) 2 The Friends of Garrett Cumming Research & Muscular Dystrophy Canada, HM Toupin Neurological Science Research Chair, Edmonton, AB T6G2H7, Canada * Correspondence: [email protected]; Tel.: +1-780-492-1102 These authors contributed equally to the work. y Received: 28 December 2019; Accepted: 19 January 2020; Published: 22 January 2020 Abstract: Cardiomyopathies are diseases of heart muscle, a significant percentage of which are genetic in origin. Cardiomyopathies can be classified as dilated, hypertrophic, restrictive, arrhythmogenic right ventricular or left ventricular non-compaction, although mixed morphologies are possible. A subset of neuromuscular disorders, notably Duchenne and Becker muscular dystrophies, are also characterized by cardiomyopathy aside from skeletal myopathy. The global burden of cardiomyopathies is certainly high, necessitating further research and novel therapies. Genome editing tools, which include zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs) and clustered regularly interspaced short palindromic repeats (CRISPR) systems have emerged as increasingly important technologies in studying
    [Show full text]
  • Supplementary Table 1: Adhesion Genes Data Set
    Supplementary Table 1: Adhesion genes data set PROBE Entrez Gene ID Celera Gene ID Gene_Symbol Gene_Name 160832 1 hCG201364.3 A1BG alpha-1-B glycoprotein 223658 1 hCG201364.3 A1BG alpha-1-B glycoprotein 212988 102 hCG40040.3 ADAM10 ADAM metallopeptidase domain 10 133411 4185 hCG28232.2 ADAM11 ADAM metallopeptidase domain 11 110695 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 195222 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 165344 8751 hCG20021.3 ADAM15 ADAM metallopeptidase domain 15 (metargidin) 189065 6868 null ADAM17 ADAM metallopeptidase domain 17 (tumor necrosis factor, alpha, converting enzyme) 108119 8728 hCG15398.4 ADAM19 ADAM metallopeptidase domain 19 (meltrin beta) 117763 8748 hCG20675.3 ADAM20 ADAM metallopeptidase domain 20 126448 8747 hCG1785634.2 ADAM21 ADAM metallopeptidase domain 21 208981 8747 hCG1785634.2|hCG2042897 ADAM21 ADAM metallopeptidase domain 21 180903 53616 hCG17212.4 ADAM22 ADAM metallopeptidase domain 22 177272 8745 hCG1811623.1 ADAM23 ADAM metallopeptidase domain 23 102384 10863 hCG1818505.1 ADAM28 ADAM metallopeptidase domain 28 119968 11086 hCG1786734.2 ADAM29 ADAM metallopeptidase domain 29 205542 11085 hCG1997196.1 ADAM30 ADAM metallopeptidase domain 30 148417 80332 hCG39255.4 ADAM33 ADAM metallopeptidase domain 33 140492 8756 hCG1789002.2 ADAM7 ADAM metallopeptidase domain 7 122603 101 hCG1816947.1 ADAM8 ADAM metallopeptidase domain 8 183965 8754 hCG1996391 ADAM9 ADAM metallopeptidase domain 9 (meltrin gamma) 129974 27299 hCG15447.3 ADAMDEC1 ADAM-like,
    [Show full text]
  • Plakophilin-2 Haploinsufficiency Causes Calcium Handling
    International Journal of Molecular Sciences Article Plakophilin-2 Haploinsufficiency Causes Calcium Handling Deficits and Modulates the Cardiac Response Towards Stress Chantal J.M. van Opbergen 1 , Maartje Noorman 1, Anna Pfenniger 2, Jaël S. Copier 1, Sarah H. Vermij 2,3 , Zhen Li 2, Roel van der Nagel 1, Mingliang Zhang 2, Jacques M.T. de Bakker 1,4, Aaron M. Glass 5, Peter J. Mohler 6,7, Steven M. Taffet 5, Marc A. Vos 1, Harold V.M. van Rijen 1, Mario Delmar 2 and Toon A.B. van Veen 1,* 1 Department of Medical Physiology, Division of Heart & Lungs, University Medical Center Utrecht, Yalelaan 50, 3584CM Utrecht, The Netherlands 2 Division of Cardiology, NYU School of Medicine, New York, NY 10016, USA 3 Institute of Biochemistry and Molecular Medicine, University of Bern, 3012 Bern, Switzerland 4 Department of Medical Biology, Academic Medical Center Amsterdam, 1105AZ Amsterdam, The Netherlands 5 Department of Microbiology and Immunology, SUNY Upstate Medical University, Syracuse, NY 13210, USA 6 Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University College of Medicine and Wexner Medical Center, Columbus, OH 43210, USA 7 Departments of Physiology & Cell Biology and Internal Medicine, Division of Cardiovascular Medicine, The Ohio State University College of Medicine Wexner Medical Center, Columbus, OH 43210, USA * Correspondence: [email protected] Received: 1 August 2019; Accepted: 19 August 2019; Published: 21 August 2019 Abstract: Human variants in plakophilin-2 (PKP2) associate with most cases of familial arrhythmogenic cardiomyopathy (ACM). Recent studies show that PKP2 not only maintains intercellular coupling, but also regulates transcription of genes involved in Ca2+ cycling and cardiac rhythm.
    [Show full text]
  • Molecular Cloning of a Functional Promoter of the Human Plakoglobin
    European Journal of Endocrinology (2001) 145 625±633 ISSN 0804-4643 EXPERIMENTAL STUDY Molecular cloning of a functional promoter of the human plakoglobin gene Eyck PoÈtter1,2, Sabine Braun1, Ulrich Lehmann3 and Georg Brabant1 1Department of Clinical Endocrinology, 2Department of Nuclear Medicine and 3Institute of Pathology, Medizinische Hochschule, D-30625 Hannover, Germany (Correspondence should be addressed to G Brabant, Klinische Endokrinologie OE6820, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, D-30625 Hannover, Germany; Email: [email protected]) Abstract Objective: Plakoglobin (Pg) is the only cytoplasmic protein component common to both junctional complexes mediating cell±cell adhesion, adherens junctions and desmosomes. In these complexes Pg appears to act as a linker protein anchoring transmembrane proteins of the cadherin superfamily to the actin cytoskeleton and intermediate ®lament system respectively. Intercellular adhesion is frequently disturbed in skin diseases and in carcinomas, enabling tumour progression and metastasis. Whereas Pg expression is lost in some thyroid tumours and carcinoma cell lines, little information on Pg gene regulation is currently available owing to a lack of promoter studies. Design and methods: We have cloned and sequenced genomic DNA from a human library that resulted in 979 bp upstream of the published Pg cDNA. The transcriptional start was mapped by rapid ampli®cation of cDNA ends. Methylation-speci®c PCR of bisul®te-modi®ed cell line DNA was applied to probe the methylation status of a promoter-associated CpG island. Reporter-gene constructs of various promoter fragments were transiently transfected in thyroid carcinoma cell lines and their activities were determined by luciferase measurements. Results and conclusions: A 1 kb DNA fragment harbouring a functional promoter of the human Pg gene was cloned and characterized.
    [Show full text]
  • Differential Gene Expression in Oligodendrocyte Progenitor Cells, Oligodendrocytes and Type II Astrocytes
    Tohoku J. Exp. Med., 2011,Differential 223, 161-176 Gene Expression in OPCs, Oligodendrocytes and Type II Astrocytes 161 Differential Gene Expression in Oligodendrocyte Progenitor Cells, Oligodendrocytes and Type II Astrocytes Jian-Guo Hu,1,2,* Yan-Xia Wang,3,* Jian-Sheng Zhou,2 Chang-Jie Chen,4 Feng-Chao Wang,1 Xing-Wu Li1 and He-Zuo Lü1,2 1Department of Clinical Laboratory Science, The First Affiliated Hospital of Bengbu Medical College, Bengbu, P.R. China 2Anhui Key Laboratory of Tissue Transplantation, Bengbu Medical College, Bengbu, P.R. China 3Department of Neurobiology, Shanghai Jiaotong University School of Medicine, Shanghai, P.R. China 4Department of Laboratory Medicine, Bengbu Medical College, Bengbu, P.R. China Oligodendrocyte precursor cells (OPCs) are bipotential progenitor cells that can differentiate into myelin-forming oligodendrocytes or functionally undetermined type II astrocytes. Transplantation of OPCs is an attractive therapy for demyelinating diseases. However, due to their bipotential differentiation potential, the majority of OPCs differentiate into astrocytes at transplanted sites. It is therefore important to understand the molecular mechanisms that regulate the transition from OPCs to oligodendrocytes or astrocytes. In this study, we isolated OPCs from the spinal cords of rat embryos (16 days old) and induced them to differentiate into oligodendrocytes or type II astrocytes in the absence or presence of 10% fetal bovine serum, respectively. RNAs were extracted from each cell population and hybridized to GeneChip with 28,700 rat genes. Using the criterion of fold change > 4 in the expression level, we identified 83 genes that were up-regulated and 89 genes that were down-regulated in oligodendrocytes, and 92 genes that were up-regulated and 86 that were down-regulated in type II astrocytes compared with OPCs.
    [Show full text]
  • 1714 Gene Comprehensive Cancer Panel Enriched for Clinically Actionable Genes with Additional Biologically Relevant Genes 400-500X Average Coverage on Tumor
    xO GENE PANEL 1714 gene comprehensive cancer panel enriched for clinically actionable genes with additional biologically relevant genes 400-500x average coverage on tumor Genes A-C Genes D-F Genes G-I Genes J-L AATK ATAD2B BTG1 CDH7 CREM DACH1 EPHA1 FES G6PC3 HGF IL18RAP JADE1 LMO1 ABCA1 ATF1 BTG2 CDK1 CRHR1 DACH2 EPHA2 FEV G6PD HIF1A IL1R1 JAK1 LMO2 ABCB1 ATM BTG3 CDK10 CRK DAXX EPHA3 FGF1 GAB1 HIF1AN IL1R2 JAK2 LMO7 ABCB11 ATR BTK CDK11A CRKL DBH EPHA4 FGF10 GAB2 HIST1H1E IL1RAP JAK3 LMTK2 ABCB4 ATRX BTRC CDK11B CRLF2 DCC EPHA5 FGF11 GABPA HIST1H3B IL20RA JARID2 LMTK3 ABCC1 AURKA BUB1 CDK12 CRTC1 DCUN1D1 EPHA6 FGF12 GALNT12 HIST1H4E IL20RB JAZF1 LPHN2 ABCC2 AURKB BUB1B CDK13 CRTC2 DCUN1D2 EPHA7 FGF13 GATA1 HLA-A IL21R JMJD1C LPHN3 ABCG1 AURKC BUB3 CDK14 CRTC3 DDB2 EPHA8 FGF14 GATA2 HLA-B IL22RA1 JMJD4 LPP ABCG2 AXIN1 C11orf30 CDK15 CSF1 DDIT3 EPHB1 FGF16 GATA3 HLF IL22RA2 JMJD6 LRP1B ABI1 AXIN2 CACNA1C CDK16 CSF1R DDR1 EPHB2 FGF17 GATA5 HLTF IL23R JMJD7 LRP5 ABL1 AXL CACNA1S CDK17 CSF2RA DDR2 EPHB3 FGF18 GATA6 HMGA1 IL2RA JMJD8 LRP6 ABL2 B2M CACNB2 CDK18 CSF2RB DDX3X EPHB4 FGF19 GDNF HMGA2 IL2RB JUN LRRK2 ACE BABAM1 CADM2 CDK19 CSF3R DDX5 EPHB6 FGF2 GFI1 HMGCR IL2RG JUNB LSM1 ACSL6 BACH1 CALR CDK2 CSK DDX6 EPOR FGF20 GFI1B HNF1A IL3 JUND LTK ACTA2 BACH2 CAMTA1 CDK20 CSNK1D DEK ERBB2 FGF21 GFRA4 HNF1B IL3RA JUP LYL1 ACTC1 BAG4 CAPRIN2 CDK3 CSNK1E DHFR ERBB3 FGF22 GGCX HNRNPA3 IL4R KAT2A LYN ACVR1 BAI3 CARD10 CDK4 CTCF DHH ERBB4 FGF23 GHR HOXA10 IL5RA KAT2B LZTR1 ACVR1B BAP1 CARD11 CDK5 CTCFL DIAPH1 ERCC1 FGF3 GID4 HOXA11 IL6R KAT5 ACVR2A
    [Show full text]
  • Fra-2 Overexpression Upregulates Pro-Metastatic Cell-Adhesion
    Fra-2 Overexpression Upregulates Pro-metastatic Cell-adhesion Molecules, Promotes Pulmonary Metastasis and Reduces Survival in a Spontaneous Xenograft Model of Human Breast Cancer Sabrina Arnold University Medical Center Hamburg-Eppendorf: Universitatsklinikum Hamburg-Eppendorf Jan Kortland University Medical Center Hamburg-Eppendorf: Universitatsklinikum Hamburg-Eppendorf Diana V. Maltseva National Faculty of Biology and Biotechnology, National Research University Higher School of Economics Timur R. Samatov Evotec International GmbH Susanne Lezius University Medical Center Hamburg-Eppendorf: Universitatsklinikum Hamburg-Eppendorf Alexander G. Tonevitsky Far Eastern Federal University Karin Milde-Langosch University Medical Center Hamburg-Eppendorf: Universitatsklinikum Hamburg-Eppendorf Daniel Wicklein University Medical Center Hamburg-Eppendorf: Universitatsklinikum Hamburg-Eppendorf Udo Schumacher University Medical Center Hamburg-Eppendorf: Universitatsklinikum Hamburg-Eppendorf Christine Stürken ( [email protected] ) endorf: Universitatsklinikum Hamburg-Eppendorf https://orcid.org/0000-0003-3997-3304 Research Article Keywords: Breast Cancer, Transcription factor, AP-1, Fra-2, Metastasis Posted Date: June 15th, 2021 DOI: https://doi.org/10.21203/rs.3.rs-592522/v1 Page 1/33 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 2/33 Abstract Purpose: The transcription factor Fra-2 affects the invasive potential of breast cancer cells by dysregulating adhesion molecules in vitro. Previous results suggested that it upregulates the expression of E- and P- selectin ligands. Such selectin ligands are important members of the leukocyte adhesion cascade, which govern the adhesion and transmigration of cancer cells into the stroma of the host organ of metastasis. As so far, no in vivo data are available, this study was designed to elucidate the role of Fra-2 expression in a spontaneous breast cancer metastasis xenograft model.
    [Show full text]
  • Identification of Key Pathways and Genes in Dementia Via Integrated Bioinformatics Analysis
    bioRxiv preprint doi: https://doi.org/10.1101/2021.04.18.440371; this version posted July 19, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Identification of Key Pathways and Genes in Dementia via Integrated Bioinformatics Analysis Basavaraj Vastrad1, Chanabasayya Vastrad*2 1. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 2. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001, Karnataka, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India bioRxiv preprint doi: https://doi.org/10.1101/2021.04.18.440371; this version posted July 19, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract To provide a better understanding of dementia at the molecular level, this study aimed to identify the genes and key pathways associated with dementia by using integrated bioinformatics analysis. Based on the expression profiling by high throughput sequencing dataset GSE153960 derived from the Gene Expression Omnibus (GEO), the differentially expressed genes (DEGs) between patients with dementia and healthy controls were identified. With DEGs, we performed a series of functional enrichment analyses. Then, a protein–protein interaction (PPI) network, modules, miRNA-hub gene regulatory network and TF-hub gene regulatory network was constructed, analyzed and visualized, with which the hub genes miRNAs and TFs nodes were screened out. Finally, validation of hub genes was performed by using receiver operating characteristic curve (ROC) analysis.
    [Show full text]
  • Genetic Cardiomyopathies: the Lesson Learned from Hipscs
    Journal of Clinical Medicine Review Genetic Cardiomyopathies: The Lesson Learned from hiPSCs Ilaria My 1,2 and Elisa Di Pasquale 2,3,* 1 Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, 20090 Milan, Italy; [email protected] 2 Humanitas Clinical and Research Center—IRCCS, Rozzano, 20089 Milan, Italy 3 Institute of Genetic and Biomedical Research (IRGB)—UOS of Milan, National Research Council (CNR), 20138 Milan, Italy * Correspondence: [email protected] Abstract: Genetic cardiomyopathies represent a wide spectrum of inherited diseases and constitute an important cause of morbidity and mortality among young people, which can manifest with heart failure, arrhythmias, and/or sudden cardiac death. Multiple underlying genetic variants and molecular pathways have been discovered in recent years; however, assessing the pathogenicity of new variants often needs in-depth characterization in order to ascertain a causal role in the disease. The application of human induced pluripotent stem cells has greatly helped to advance our knowledge in this field and enabled to obtain numerous in vitro patient-specific cellular models useful to study the underlying molecular mechanisms and test new therapeutic strategies. A milestone in the research of genetically determined heart disease was the introduction of genomic technologies that provided unparalleled opportunities to explore the genetic architecture of cardiomyopathies, thanks to the generation of isogenic pairs. The aim of this review is to provide an overview of the main research that helped elucidate the pathophysiology of the most common genetic cardiomyopathies: hypertrophic, dilated, arrhythmogenic, and left ventricular noncompaction cardiomyopathies. A special focus is provided on the application of gene-editing techniques in understanding key disease characteristics and on the therapeutic approaches that have been tested.
    [Show full text]
  • Human Induced Pluripotent Stem Cell–Derived Podocytes Mature Into Vascularized Glomeruli Upon Experimental Transplantation
    BASIC RESEARCH www.jasn.org Human Induced Pluripotent Stem Cell–Derived Podocytes Mature into Vascularized Glomeruli upon Experimental Transplantation † Sazia Sharmin,* Atsuhiro Taguchi,* Yusuke Kaku,* Yasuhiro Yoshimura,* Tomoko Ohmori,* ‡ † ‡ Tetsushi Sakuma, Masashi Mukoyama, Takashi Yamamoto, Hidetake Kurihara,§ and | Ryuichi Nishinakamura* *Department of Kidney Development, Institute of Molecular Embryology and Genetics, and †Department of Nephrology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan; ‡Department of Mathematical and Life Sciences, Graduate School of Science, Hiroshima University, Hiroshima, Japan; §Division of Anatomy, Juntendo University School of Medicine, Tokyo, Japan; and |Japan Science and Technology Agency, CREST, Kumamoto, Japan ABSTRACT Glomerular podocytes express proteins, such as nephrin, that constitute the slit diaphragm, thereby contributing to the filtration process in the kidney. Glomerular development has been analyzed mainly in mice, whereas analysis of human kidney development has been minimal because of limited access to embryonic kidneys. We previously reported the induction of three-dimensional primordial glomeruli from human induced pluripotent stem (iPS) cells. Here, using transcription activator–like effector nuclease-mediated homologous recombination, we generated human iPS cell lines that express green fluorescent protein (GFP) in the NPHS1 locus, which encodes nephrin, and we show that GFP expression facilitated accurate visualization of nephrin-positive podocyte formation in
    [Show full text]